Skip to main content
. 2018 May 29;90(22):e1989–e1996. doi: 10.1212/WNL.0000000000005610

Figure 2. [11C]PK11195 binding correlates with clinical severity in AD and PSP.

Figure 2

(A) Correlation between [11C]PK11195 BPND values in the precuneus (x-axis) and RAVLT scores (y-axis) in patients with AD and MCI+ (red dots). (B–D) Correlation between [11C]PK11195 BPND values in the pallidum, midbrain, and pons (x-axes) and PSP Rating Scale (y-axes) in patients with PSP. AD = Alzheimer disease; BPND = nondisplaceable binding potential; MCI+ = amyloid-positive mild cognitive impairment; PSP = progressive supranuclear palsy; RAVLT = Rey Auditory Verbal Learning Test.